Drugmaker Dr. Reddy’s Laboratories reported an 8% drop in consolidated net profit for the June quarter of fiscal year 2026–27, as increased competition and ongoing price erosion in its primary North American market curtailed bottom-line growth.US Market DragThe company posted a c







